Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3748/wjg.v21.i42.12179 http://scihub22266oqcxt.onion/10.3748/wjg.v21.i42.12179 C4641135!4641135 !26576102     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=26576102 &cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\26576102 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       World+J+Gastroenterol 2015 ; 21 (42 ): 12179-89 Nephropedia Template TP {{tp|p=26576102 |t=2015. Autoimmune gastritis: Pathologist s viewpoint |pdf=|usr=}}{{26576102 }} gab.com Text Autoimmune gastritis: Pathologist s viewpoint JO: World J Gastroenterol http://www.kidney.de/pget.php?&tw=1&pmid=26576102 #FOAvip Western countries are seeing a constant decline in the incidence of Helicobacter pylori-associated gastritis, coupled with a rising epidemiological and clinical impact of autoimmune gastritis. This latter gastropathy is due to autoimmune aggression targeting parietal cells through a complex interaction of auto-antibodies against the parietal cell proton pump and intrinsic factor, and sensitized T cells. Given the specific target of this aggression, autoimmune gastritis is typically restricted to the gastric corpus-fundus mucosa. In advanced cases, the oxyntic epithelia are replaced by atrophic (and metaplastic) mucosa, creating the phenotypic background in which both gastric neuroendocrine tumors and (intestinal-type) adenocarcinomas may develop. Despite improvements in our understanding of the phenotypic changes or cascades occurring in this autoimmune setting, no reliable biomarkers are available for identifying patients at higher risk of developing a gastric neoplasm. The standardization of autoimmune gastritis histology reports and classifications in diagnostic practice is a prerequisite for implementing definitive secondary prevention strategies based on multidisciplinary diagnostic approaches integrating endoscopy, serology, histology and molecular profiling. Twit Text FOAVip Autoimmune gastritis: Pathologist s viewpoint ????World J Gastroenterol http://www.kidney.de/pget.php?&tw=1&pmid=26576102 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26576102 #FOAvip English Wikipedia <ref>{{Cite pmid|26576102 }}</ref> Autoimmune gastritis: Pathologist s viewpoint #MMPMID26576102 Coati I ; Fassan M ; Farinati F ; Graham DY ; Genta RM ; Rugge M World J Gastroenterol 2015[Nov]; 21 (42 ): 12179-89 PMID26576102 show ga Western countries are seeing a constant decline in the incidence of Helicobacter pylori-associated gastritis, coupled with a rising epidemiological and clinical impact of autoimmune gastritis. This latter gastropathy is due to autoimmune aggression targeting parietal cells through a complex interaction of auto-antibodies against the parietal cell proton pump and intrinsic factor, and sensitized T cells. Given the specific target of this aggression, autoimmune gastritis is typically restricted to the gastric corpus-fundus mucosa. In advanced cases, the oxyntic epithelia are replaced by atrophic (and metaplastic) mucosa, creating the phenotypic background in which both gastric neuroendocrine tumors and (intestinal-type) adenocarcinomas may develop. Despite improvements in our understanding of the phenotypic changes or cascades occurring in this autoimmune setting, no reliable biomarkers are available for identifying patients at higher risk of developing a gastric neoplasm. The standardization of autoimmune gastritis histology reports and classifications in diagnostic practice is a prerequisite for implementing definitive secondary prevention strategies based on multidisciplinary diagnostic approaches integrating endoscopy, serology, histology and molecular profiling. |Autoimmune Diseases/epidemiology/immunology/*pathology/therapy [MESH] |Autoimmunity [MESH] |Biomarkers/analysis [MESH] |Biopsy [MESH] |Gastritis/epidemiology/immunology/*pathology/therapy [MESH] |Humans [MESH] |Immunohistochemistry [MESH] |Pathology/*methods [MESH] |Predictive Value of Tests [MESH] |Prognosis [MESH] |Stem Cells/chemistry/immunology/*pathology [MESH]Autoimmune gastritis: Pathologist s viewpoint (epmc).pdf DeepDyve Pubget Overpricing